Literature DB >> 23324999

Lithium's gene expression profile, relevance to neuroprotection A cDNA microarray study.

Raymond Farah1, Rola Khamisy-Farah, Tamar Amit, Moussa B H Youdim, Zaher Arraf.   

Abstract

Lithium can prevent 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) dopaminergic neurotoxicity in mice. This is attributed to induced antioxidant and antiapoptotic state, which among other factors results from induction of Bcl-2 and reduction of Bax, however, cDNA microarray reveals that this represents only one cascade of lithium targets. From analyzing the gene expression profile of lithium, we are able to point out candidate genes that might be involved in the antioxidant and neuroprotective properties of lithium. Among these are, the cAMP response element binding (CREB) protein, extracellular signal-regulated kinase (ERK), both CREB and ERK-part of the mitogen-activated kinase pathway-were upregulated by lithium, downregulated by MPTP, and maintained in mice fed with lithium chloride (LiCl) supplemented diet and treated with MPTP. Our positive control included tyrosine hydroxylase which both its mRNA and protein levels were independently measured, in addition to Bcl-2 protein levels. Other important genes which were similarly regulated are plasma glutathione peroxidase precursor (GSHPX-P), protein kinase C alpha type, insulin-like growth factor binding protein 4 precursor, and interferon regulatory factor. In addition, some genes were oppositely regulated, i.e., downregulated by lithium, upregulated by MPTP, and maintained in mice fed with LiCl supplemented diet and treated with MPTP, among these genes were basic fibroblast growth factor receptor 1 precursor, inhibin alpha subunit, glutamate receptor subunit zeta 1 precursor (NMD-R1), postsynaptic density protein-95 which together with NMD-R1 can form an apoptotic promoting complex. The discussed targets represent part of genes altered by chronic lithium. In fact lithium affected the expressions of more than 50 genes among these were basic transcription factors, transcription activators, cell signaling proteins, cell adhesion proteins, oncogenes and tumor suppressors, intracellular transducers, survival and death genes, and cyclins, here we discuss the relevance of these changes to lithium's reported neuroprotective properties.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23324999     DOI: 10.1007/s10571-013-9907-x

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   4.231


  72 in total

Review 1.  Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness.

Authors:  H K Manji; G J Moore; G Chen
Journal:  J Clin Psychiatry       Date:  2000       Impact factor: 4.384

Review 2.  Statistical issues with microarrays: processing and analysis.

Authors:  Robert Nadon; Jennifer Shoemaker
Journal:  Trends Genet       Date:  2002-05       Impact factor: 11.639

Review 3.  Powerful tools for genetic analysis come of age.

Authors:  D J Graves
Journal:  Trends Biotechnol       Date:  1999-03       Impact factor: 19.536

4.  The NMDA receptor/nitric oxide pathway: a target for the therapeutic and toxic effects of lithium.

Authors:  Mehdi Ghasemi; Ahmad Reza Dehpour
Journal:  Trends Pharmacol Sci       Date:  2011-04-13       Impact factor: 14.819

5.  Transgenic mice expressing human Bcl-2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine neurotoxicity.

Authors:  D Offen; P M Beart; N S Cheung; C J Pascoe; A Hochman; S Gorodin; E Melamed; R Bernard; O Bernard
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

6.  Short chain fatty acids induce TH gene expression via ERK-dependent phosphorylation of CREB protein.

Authors:  Parul Shah; Bistra B Nankova; Santosh Parab; Edmund F La Gamma
Journal:  Brain Res       Date:  2006-07-18       Impact factor: 3.252

7.  Lithium-induced increase in human brain grey matter.

Authors:  G J Moore; J M Bebchuk; I B Wilds; G Chen; H K Manji; H K Menji
Journal:  Lancet       Date:  2000-10-07       Impact factor: 79.321

8.  Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity.

Authors:  S Przedborski; V Jackson-Lewis; R Yokoyama; T Shibata; V L Dawson; T M Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

9.  [Effects of lithium on the activity of ERK-1/2 signal pathway and expression of Bcl-2 family proteins in the central nervous system in vivo].

Authors:  Jian-ling Li; Zhao-zheng Jing; Hong Yi
Journal:  Hunan Yi Ke Da Xue Xue Bao       Date:  2003-08

10.  Chronic lithium treatment decreases mutant tau protein aggregation in a transgenic mouse model.

Authors:  Mar Pérez; Félix Hernández; Filip Lim; Javier Díaz-Nido; Jesús Avila
Journal:  J Alzheimers Dis       Date:  2003-08       Impact factor: 4.472

View more
  8 in total

Review 1.  Therapeutic Mechanisms of Lithium in Bipolar Disorder: Recent Advances and Current Understanding.

Authors:  Gin S Malhi; Tim Outhred
Journal:  CNS Drugs       Date:  2016-10       Impact factor: 5.749

2.  The combination of lithium and l-Dopa/Carbidopa reduces MPTP-induced abnormal involuntary movements (AIMs) via calpain-1 inhibition in a mouse model: Relevance for Parkinson׳s disease therapy.

Authors:  Carol A Lazzara; Rebeccah R Riley; Anand Rane; Julie K Andersen; Yong-Hwan Kim
Journal:  Brain Res       Date:  2015-06-26       Impact factor: 3.252

3.  Neuroprotective effects of farnesene against hydrogen peroxide-induced neurotoxicity in vitro.

Authors:  Hasan Turkez; Piera Sozio; Fatime Geyikoglu; Abdulgani Tatar; Ahmet Hacimuftuoglu; Antonio Di Stefano
Journal:  Cell Mol Neurobiol       Date:  2013-10-09       Impact factor: 5.046

4.  Protective effects of cyclosativene on H2O 2-induced injury in cultured rat primary cerebral cortex cells.

Authors:  Hasan Turkez; Basak Togar; Antonio Di Stefano; Numan Taspınar; Piera Sozio
Journal:  Cytotechnology       Date:  2014-02-04       Impact factor: 2.058

Review 5.  A new avenue for lithium: intervention in traumatic brain injury.

Authors:  Peter R Leeds; Fengshan Yu; Zhifei Wang; Chi-Tso Chiu; Yumin Zhang; Yan Leng; Gabriel R Linares; De-Maw Chuang
Journal:  ACS Chem Neurosci       Date:  2014-04-11       Impact factor: 4.418

Review 6.  Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics.

Authors:  M Alda
Journal:  Mol Psychiatry       Date:  2015-02-17       Impact factor: 15.992

7.  Lithium promotes DNA stability and survival of ischemic retinal neurocytes by upregulating DNA ligase IV.

Authors:  Ying Yang; Nandan Wu; Sijia Tian; Fan Li; Huan Hu; Pei Chen; Xiaoxiao Cai; Lijun Xu; Jing Zhang; Zhao Chen; Jian Ge; Keming Yu; Jing Zhuang
Journal:  Cell Death Dis       Date:  2016-11-17       Impact factor: 8.469

Review 8.  Targeting Tau to Treat Clinical Features of Huntington's Disease.

Authors:  Maria Masnata; Shireen Salem; Aurelie de Rus Jacquet; Mehwish Anwer; Francesca Cicchetti
Journal:  Front Neurol       Date:  2020-11-19       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.